African trypanosomiasis, known as African sleeping sickness or simply sleeping sickness, is an insect-borne parasitic infection of humans and other animals.
| FactSnippet No. 972,371 |
African trypanosomiasis, known as African sleeping sickness or simply sleeping sickness, is an insect-borne parasitic infection of humans and other animals.
| FactSnippet No. 972,371 |
African trypanosomiasis symptoms occur in two stages: the hemolymphatic stage and the neurological stage .
| FactSnippet No. 972,372 |
African trypanosomiasis is dependent on the interaction of the parasite with the tsetse flies, as well as the host .
| FactSnippet No. 972,373 |
The risk of contracting African trypanosomiasis is dependent on coming in contact with an infected tsetse fly.
| FactSnippet No. 972,374 |
Entire life cycle of African trypanosomiasis trypanosomes is represented by extracellular stages.
| FactSnippet No. 972,375 |
Additionally, the Drugs for Neglected Diseases Initiative has contributed to the African trypanosomiasis sleeping sickness research by developing a compound called fexinidazole.
| FactSnippet No. 972,376 |
Kinetoplastid infections include African trypanosomiasis sleeping sickness, Chagas' disease, and Leishmaniasis.
| FactSnippet No. 972,377 |
Each of the three diseases, African trypanosomiasis sleeping sickness, Chagas' disease, and Leishmaniasis each received approximately a third of the funding, which was about $36.
| FactSnippet No. 972,378 |
Much of the progress that has been made in African trypanosomiasis sleeping sickness and neglected disease research as a whole is a result of the other non-public funders.
| FactSnippet No. 972,379 |
African trypanosomiasis has generally been considered an anthroponotic disease and thus its control program was mainly focused on stopping the transmission by treating human cases and eliminating the vector.
| FactSnippet No. 972,380 |